40 Results for "

Antitumoral

" in MedChemExpress (MCE) Product Catalog:
Products (40)

40 Results for "Antitumoral" in MCE Product Catalog:

18
18 Publications Verification
Cat. No.: HY-15433
CAS No.: 875320-29-9
Purity:  99.71%
Synonyms: JNJ-26481585
Target:  

HDAC Autophagy

Research Areas:  

Inflammation/Immunology Cancer

Quisinostat (JNJ-26481585) is a potent and orally active pan-HDAC inhibitor (HDACi), with IC50 values ranging from 0.11 nM to 0.64 nM for HDAC1, HDAC2, HDAC4, HDAC10 and HDAC11. Quisinostat has a broad spectrum antitumoral activity . Quisinostat can induce autophagy in neuroblastoma cells .
loading...
    loading...
18
18 Publications Verification
Cat. No.: HY-15433A
CAS No.: 875320-31-3
Purity:  99.05%
Synonyms: JNJ-26481585 dihydrochloride
Target:  

HDAC Autophagy

Research Areas:  

Inflammation/Immunology Cancer

Quisinostat dihydrochloride (JNJ-26481585 dihydrochloride) is an orally active, potent pan-HDAC inhibitor with IC50s of 0.11 nM, 0.33 nM, 0.64 nM, 0.46 nM, and 0.37 nM for HDAC1, HDAC2, HDAC4, HDAC10 and HDAC11, respectively. Quisinostat dihydrochloride has a broad spectrum antitumoral activity. Quisinostat dihydrochloride can induce autophagy in neuroblastoma cells .
loading...
    loading...
9
9 Cited Publications
Cat. No.: HY-N0187
CAS No.: 90-33-5
Synonyms: Hymecromone; 4-MU
4-Methylumbelliferone is a hyaluronic acid biosynthesis inhibitor with antitumoral and antimetastatic effects.
loading...
    loading...
9
9 Cited Publications
Cat. No.: HY-120350
CAS No.: 2163056-91-3
Purity:  99.84%
Target:  

CDK

Research Areas:  

Cancer

BI-1347 is an orally active, selective and potent CDK8 inhibitor (IC50=1.1 nM). BI-1347 shows anti-tumoral activity .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-N0628
CAS No.: 482-38-2
Synonyms: Lespedin; Lespenephryl
Kaempferitrin is a natural flavonoid, possesses antinociceptive, anti-inflammatory, anti-diabetic, antitumoral and chemopreventive effects, and activates insulin signaling pathway.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-108431
CAS No.: 203192-01-2
Purity:  99.72%
Target:  

Apoptosis

Research Areas:  

Cancer

MN58b is a selective choline kinase α (CHKα) inhibitor, and results in inhibition of phosphocholine synthesis. MN58b reduces cell growth through the induction of apoptosis, and also has antitumoral activity .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-14406A
CAS No.: 148687-76-7
Purity:  99.30%
Target:  

Neurokinin Receptor

Research Areas:  

Neurological Disease Cancer

L-733060 hydrochloride is a selective neurokinin-1 (NK-1) receptor antagonist. L-733060 hydrochloride mainly regulates pain transmission and neural plasticity by blocking the binding of Substance P (P substance) to the NK-1 receptor. L-733060 hydrochloride blocks the promoting effect of Substance P on long-term potentiation (LTP) in the hippocampus. L-733060 hydrochloride reverses the orofacial hyperalgesia induced by experimental occlusal interference (EOI) in rats. L-733060 hydrochloride hydrochloride inhibits neurogenic plasma extravasation at a dose that does not cause adverse cardiovascular effects in rodents, and also acts as an anti-tumor agent. L-733060 hydrochloride can be used for the study of chronic orofacial pain .
loading...
    loading...
Cat. No.: HY-101144
CAS No.: 850807-63-5
Purity:  98.44%
Synonyms: TCD-717
Target:  

Choline Kinase

Research Areas:  

Cancer

RSM-932A (TCD-717) is a specific ChoKα inhibitor with IC50s of 1 and 33 μM for human recombinant ChoKα and ChoKβ enzymes, respectively. RSM-932A acts as the “first in humans” compound targeting ChoKα. RSM-932A is potent in vitro anti-proliferative and in vivo anti-tumoral activity against human xenografts in mice, showing high efficacy with low toxicity profiles .
loading...
    loading...
Cat. No.: HY-13626
CAS No.: 196497-48-0
Purity:  ≥99.0%
Synonyms: ES-285
Spisulosine (ES-285) is an antiproliferative (antitumoral) compound of marine origin. Spisulosine inhibits the growth of the prostate PC-3 and LNCaP cells through intracellular ceramide accumulation and PKCζ activation. Spisulosine induces apoptosis in PC-3 and LNCaP cells .
loading...
    loading...
Cat. No.: HY-133016
CAS No.: 1464842-09-8
Purity:  99.36%
Target:  

MetAP

Research Areas:  

Cardiovascular Disease Cancer

M8891 is an orally active, reversible and brain penetrant Methionine Aminopeptidase-2 (MetAP-2) inhibitor with an IC50 of 54 nM and a Ki of 4.33 nM. M8891 does not inhibit MetAP-1 (IC50>10 µM) . M8891 inhibits growth of primary endothelial cells as well as tumor cells and demonstrates antiangiogenic and antitumoral activity .
loading...
    loading...
Cat. No.: HY-P5581
CAS No.: 347884-61-1
Alloferon 1 is an antiviral and antitumoral peptide. Alloferon 1 stimulates natural cytotoxicity of human peripheral blood lymphocytes. Alloferon 1 also induces IFN synthesis, and enhances antiviral and antitumor resistance in mice. Alloferon 1 also shows anti-inflammatory activity in λ-carrageenan-induced paw edema model. Alloferon 1 can be isolated from the blood of the blow fly Calliphora vicina (Diptera) .
loading...
    loading...
Cat. No.: HY-106019
CAS No.: 115575-11-6
Purity:  98.83%
Synonyms: R75251
Liarozole (R75251; R85246) is an imidazole derivative and orally active retinoic acid (RA) metabolism-blocking agent (RAMBA). Liarozole inhibits the cytochrome P450 (CYP26)-dependent 4-hydroxylation of retinoic acid (IC50=7 μM), resulting in increased tissue levels of retinoic acid. Liarozole shows antitumoral properties .
loading...
    loading...
Cat. No.: HY-N0187R
CAS No.: 90-33-5
Synonyms: Hymecromone (Standard); 4-MU (Standard)
4-Methylumbelliferone (Standard) is the analytical standard of 4-Methylumbelliferone. This product is intended for research and analytical applications. 4-Methylumbelliferone is a hyaluronic acid biosynthesis inhibitor with antitumoral and antimetastatic effects.
loading...
    loading...
Cat. No.: HY-128763
CAS No.: 1252003-13-6
Purity:  98.82%
Target:  

HDAC

Research Areas:  

Cancer

HDAC-IN-4 is a selective HDAC6 and HDAC10 inhibitor with pIC50s of 7.2 and 6.8 in BRET assay, respectively. Antitumoral activity .
loading...
    loading...
Cat. No.: HY-106019C
CAS No.: 1883548-96-6
Purity:  99.04%
Synonyms: R75251 dihydrochloride
Liarozole (R75251) dihydrochloride is an imidazole derivative and orally active retinoic acid (RA) metabolism-blocking agent (RAMBA). Liarozole dihydrochloride inhibits the cytochrome P450 (CYP26)-dependent 4-hydroxylation of RA (IC50=7 μM), resulting in increased tissue levels of RA. Liarozole dihydrochloride shows antitumoral properties .
loading...
    loading...
Cat. No.: HY-130326
CAS No.: 372948-28-2
Purity:  99.30%
Synonyms: Ru(η6-p-cymene)Cl2(pta)
Target:  

Apoptosis Caspase

Research Areas:  

Cardiovascular Disease Cancer

RAPTA-C (Ru(η6-p-cymene)Cl2(pta)) acts as an anti-cancer and anti-angiogenic agent. RAPTA-C exhibits anti-metastatic, anti-angiogenic, and anti-tumoral activities through protein and histone-deoxyribonucleic acid alterations. RAPTA-C exhibits cell growth inhibition by triggering G(2)/M phase arrest in cancer cells. RAPTA-C also enhances the levels of p53 and triggers the mitochondrial Apoptotic pathway, resulting in cytochrome C release and caspase-9 activation. RAPTA-C reduces the growth of tumors with the inhibition of angiogenesis in a ovarian carcinoma model .
loading...
    loading...
Cat. No.: HY-P10759
CAS No.: 372491-73-1
Research Areas:  

Cancer

DTS-201 sodium (CPI-0004Na) is a peptidic prodrug of Doxorubicin (HY-15142A). DTS-201, comprising the tetrapeptide portion, is cleaved by endopeptidases in the tumor environment to produce metabolites that subsequently enter the cell and are converted to active Doxorubicin. DTS-201 shows antitumoral efficacy in tumor xenograft models of prostate, breast, and lung cancer .
loading...
    loading...
Cat. No.: HY-15433B
CAS No.: 1083078-98-1
Synonyms: JNJ26481585 hydrochloride
Target:  

HDAC Autophagy

Research Areas:  

Cancer

Quisinostat (JNJ-26481585) hydrochloride is a potent and orally active pan-HDAC inhibitor (HDACi), with IC50 values ranging from 0.11 nM to 0.64 nM for HDAC1, HDAC2, HDAC4, HDAC10 and HDAC11. Quisinostat hydrochloride has a broad spectrum antitumoral activity. Quisinostat hydrochloride can induce autophagy in neuroblastoma cells .
loading...
    loading...
Cat. No.: HY-164487
CAS No.: 2401867-58-9
Target:  

Proteasome

Research Areas:  

Cancer

JBJ-08-178-01 is a mutant-selective tyrosine kinase inhibitor against human epidermal growth factor receptor 2 (HER2) with an antitumoral activity. JBJ-08-178-01 reduces both the kinase activity and protein levels of HER2 by inducing proteasomal degradation of the receptor in lung cancer. JBJ-08-178-01 is promising for research of non-small-cell lung cancer .
loading...
    loading...
Cat. No.: HY-N10402
CAS No.: 1187954-93-3
Norbatzelladine L (Compound 2) is an inhibitor of the catalytic and functional activity of Pdr5p transporter. Norbatzelladine L inhibits Pdr5p ATPase activity with an IC50 of 3.8 µM. Norbatzelladine L shows antifungal, antiparasitic, antiviral, antibacterial and antitumoral activities .
loading...
    loading...